Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
EPAM Systems
EPAM
$5.16B
| $99.5M | 0.01% |
485,820
-44,060
| -8% | -$7.85M |
|
1452
Taysha Gene Therapies
TSHA
$1.84B
| $99.4M | 0.01% |
18,078,518
-1,229,085
| -6% | -$5.97M |
|
1453
Takeda Pharmaceutical
TAK
$55.8B
| $99.4M | 0.01% |
6,373,202
-1,317,213
| -17% | -$18.8M |
|
1454
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.08B
| $99.3M | 0.01% |
1,095,075
-5,468
| -0.5% | -$487K |
|
1455
Avantis Core Fixed Income ETF
AVIG
$1.96B
| $99.2M | 0.01% |
2,366,751
+1,031,312
| +77% | +$43.4M |
|
|
EVV
1456
Eaton Vance Limited Duration Income Fund
EVV
$1.08B
| $99.1M | 0.01% |
10,003,565
-44,483
| -0.4% | -$446K |
|
1457
iShares US Consumer Discretionary ETF
IYC
$1.23B
| $99.1M | 0.01% |
961,133
-102,694
| -10% | -$10.6M |
|
1458
NNN REIT
NNN
$8.71B
| $99M | 0.01% |
2,499,244
+107,889
| +5% | +$4.42M |
|
1459
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.54B
| $98.9M | 0.01% |
4,676,640
+643,987
| +16% | +$13.6M |
|
1460
Kilroy Realty
KRC
$4.31B
| $98.8M | 0.01% |
2,643,973
+1,846,325
| +231% | +$75.5M |
|
1461
Independence Realty Trust
IRT
$3.94B
| $98.8M | 0.01% |
5,649,829
+3,824,512
| +210% | +$63.4M |
|
1462
WisdomTree US Total Dividend Fund
DTD
$1.69B
| $98.7M | 0.01% |
1,162,988
+52,594
| +5% | +$4.43M |
|
1463
Lemonade
LMND
$4.11B
| $98.3M | 0.01% |
1,381,573
+70,320
| +5% | +$4.72M |
|
1464
Alamos Gold
AGI
$14.1B
| $98.3M | 0.01% |
2,548,632
-566,841
| -18% | -$19.7M |
|
1465
Sibanye-Stillwater
SBSW
$7.55B
| $98.3M | 0.01% |
6,898,349
-2,752,948
| -29% | -$33.3M |
|
1466
Flowserve
FLS
$10.3B
| $98.1M | 0.01% |
1,414,342
-122,686
| -8% | -$7.88M |
|
1467
Arrowhead Research
ARWR
$12.7B
| $98M | 0.01% |
1,476,005
-226,669
| -13% | -$11.1M |
|
1468
Oscar Health
OSCR
$8.52B
| $97.9M | 0.01% |
6,814,046
+2,043,758
| +43% | +$35.4M |
|
1469
American States Water
AWR
$3.42B
| $97.6M | 0.01% |
1,347,240
+758,452
| +129% | +$55.8M |
|
1470
JFrog
FROG
$10.6B
| $97.6M | 0.01% |
1,562,151
+1,321,899
| +550% | +$75.2M |
|
1471
Encompass Health
EHC
$12.5B
| $97.5M | 0.01% |
919,028
+130,818
| +17% | +$15.2M |
|
1472
Nutanix
NTNX
$17.5B
| $97.5M | 0.01% |
1,886,770
-1,289,966
| -41% | -$78.8M |
|
1473
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.21B
| $97.5M | 0.01% |
1,035,279
+261,431
| +34% | +$24.7M |
|
1474
Criteo S.A. Ordinary Shares
CRTO
$888M
| $97.4M | 0.01% |
4,723,794
+838,523
| +22% | +$17.3M |
|
|
CCC
1475
CCC Intelligent Solutions
CCC
$4.08B
| $97.3M | 0.01% |
12,233,467
-969,117
| -7% | -$7.88M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.